Succinylcholine Chloride Injection
Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
Yes — there is an active recall. 4 ongoing FDA recalls mention Succinylcholine (45 total). Check the affected lots below.
Most common reason: Sterility / contamination (34 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Succinylcholine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of assurance of sterility:
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.
Lack of Assurance of Sterility
CGMP Deviations: recalling drug products following an FDA inspection.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of sterility assurance
Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
Labeling: Incorrect or Missing lot and/or expiration date: The lot number and BUD were printed in the incorrect position on the product label making it illegible.
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Incorrect labeling: Incorrect or missing lot and/or exp date
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Lack of sterility assurance.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.